Skip to main content
. 2015 Mar 23;41(4):859–868. doi: 10.1093/schbul/sbv022

Table 1.

Baseline Demographic and Clinical Information

Aerobic Exercise (n = 16) Treatment as Usual (n = 17) t/X 2 P
Age 36.56 (10.37) 37.24 (9.85) .19 .85
Sex (% female) 37% 35% .02 .89
Ethnicity (% Hispanic) 43% 29% .69 .39
Race
 Caucasian 2 (12%) 6 (35%) 2.97 .40
 Black/African-American 6 (37%) 6 (35%)
 Asian 2 (12%) 2 (12%)
 More than one race 6 (37%) 3 (18%)
Symptoms
 Positive (SAPS Global Scores Total) 3.77 (3.37) 3.46 (2.93) .25 .81
 Negative (SANS Global Scores Total) 9.73 (4.24) 8.54 (4.41) .67 .51
 Depression (BDI Total) 7.81 (7.69) 7.23 (8.57) .20 .84
 Anxiety (BAI Total) 4.56 (4.40) 5.82 (6.83) .63 .54
Medications
 Antipsychotics (Chlorpromazine Equiv.) 258.85 (232.51) 439.73 (362.78) 1.69 .10
 Antidepressants (% yes) 44% 35% .25 .62
 SSRIs (% yes) 31% 23% .25 .62
Smoking cigarettes (% yes) 25% 23% .02 .89
 If yes, how many per day? 8.33 (9.27) 6.50 (6.83) .39 .70
Neurocognition (MCCB composite score) 33.08 (11.21) 34.23 (12.91) .34 .81
Reading ability (WTAR total) 32.50 (11.56) 37.59 (7.95) 1.48 .15
Aerobic fitness
 VO2 peak (ml/kg/min) 21.21 (7.69) 22.88 (4.41) .77 .45
 VO2 (L/min) .34 (.06) .32 (.06) .77 .45
Body mass index 31.60 (6.57) 30.75 (5.51) .40 .69
Weight (pounds) 205.23 (44.79) 204.32 (37.07) .06 .95
Heart rate 85.08 (16.16) 90.84 (15.93) .92 .37
Blood pressure
 Systolic 112.92 (14.93) 112.38 (10.54) .11 .92
 Diastolic 70.31 (7.54) 72.77 (7.86) .81 .42
Brain-derived neurotrophic factor (ng/ml) 28.1 (8.0) 31.2 (6.5) .34 .29

Note: n = 33 (schizophrenia = 26; schizoaffective disorder = 7); SAPS, Scale for Assessment of Positive Symptoms; SANS, Scale for Assessment of Negative Symptoms; BDI, Beck Depression Inventory; BAI, Beck Anxiety Inventory; SSRI, Serotonin-Specific Reuptake Inhibitor; MCCB, MATRICS Consensus Cognitive Battery; WTAR, Wechsler Test of Adult Reading.

HHS Vulnerability Disclosure